Usman Azam - Sep 29, 2025 Form 4 Insider Report for Cue Biopharma, Inc. (CUE)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Usman Azam by Michael Meluzio, attorney-in-fact
Stock symbol
CUE
Transactions as of
Sep 29, 2025
Transactions value $
$0
Form type
4
Date filed
10/2/2025, 08:13 PM
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Azam Usman CHIEF EXECUTIVE OFFICER, Director C/O CUE BIOPHARMA, INC., 40 GUEST STREET, BOSTON /s/ Usman Azam by Michael Meluzio, attorney-in-fact 2025-10-02 0002089768

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CUE Stock Option (right to buy) Award $0 +1.88M $0.00 1.88M Sep 29, 2025 Common Stock 1.88M $0.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option becomes exercisable in 48 monthly installments beginning on September 29, 2026.